For the readers interested in the stock health of Adagio Therapeutics Inc. (ADGI). It is currently valued at $30.74. When the transactions were called off in the previous session, Stock hit the highs of $35.025, after setting-off with the price of $35.01. Company’s stock value dipped to $29.78 during the trading on the day. When the trading was stopped its value was $34.95.Recently in News on September 29, 2021, Adagio Therapeutics to Participate in the Guggenheim 2nd Annual Vaccines & Infectious Day Conference. Adagio Therapeutics, Inc., (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced that management will participate in a fireside chat during the Guggenheim 2nd Annual Vaccines & Infectious Day Conference on Wednesday, Oct. 6, 2021 at 1:30 p.m. ET. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Adagio Therapeutics Inc. shares are logging -48.34% during the 52-week period from high price, and 49.95% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $20.50 and $59.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 557512 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Adagio Therapeutics Inc. (ADGI) recorded performance in the market was 47.22%. At the time of this writing, the total market value of the company is set at 3.13B, as it employees total of 68 workers.
Adagio Therapeutics Inc. (ADGI) in the eye of market guru’s
During the last month, 0 analysts gave the Adagio Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
Adagio Therapeutics Inc. (ADGI): Stocks Technical analysis and Trends
In the last 20 days, the company’s Stochastic %K was 27.88% and its Stochastic %D was recorded 28.99%.
If we look into the earlier routines of Adagio Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 47.22%. The shares increased approximately by -0.74% in the 7-day charts and went up by -37.74% in the period of the last 30 days.